Participation-Focused Training Improves Immediate Post-Stroke Executive Function in Randomized Trial

Addressing Cognitive Decline in Post-Stroke Rehabilitation

Post-stroke cognitive impairment affects approximately 53.4 percent of survivors, significantly increasing hospitalization rates and care costs while diminishing functional independence [1, 2]. While various non-pharmacological interventions, including computer-based training and non-invasive brain stimulation, have been explored, the most efficacious strategy for long-term recovery remains elusive [3, 4]. Clinicians frequently encounter patients whose cognitive deficits hinder social and physical functioning, yet traditional rehabilitation often fails to translate into sustained quality of life improvements [1, 3]. Current evidence suggests that while multimodal approaches may offer some benefits, there is a critical need for rigorous trials evaluating interventions that bridge the gap between clinical exercises and real-world participation [2, 4]. A recent randomized controlled trial now evaluates whether a participation-focused strategy training program can address these persistent cognitive challenges in community-dwelling adults.

Trial Design and Intervention Parameters

The researchers conducted an assessor-blinded randomized controlled trial, registered under ClinicalTrials.gov identifier NCT03792061, to evaluate the efficacy of the Optimizing Participation after Stroke through Strategy training (OPASS) program. This intervention was specifically designed to address cognitive and health-related quality of life outcomes in stroke survivors. The study enrolled 195 community-dwelling adults who presented with documented post-stroke cognitive impairments. These participants were randomized into two distinct cohorts to compare the strategy-based approach against a standard of care. The OPASS experimental group consisted of 96 participants, while the dose-matched control intervention (DMCI) group included 99 participants. To ensure a rigorous comparison of treatment effects, both the OPASS and DMCI groups received an identical volume of therapy, consisting of 12 to 15 sessions delivered over a period of 6 to 8 weeks. This dose-matched design allowed the authors to isolate the specific impact of the participation-focused strategy training from the general benefits of therapeutic engagement. Clinical outcomes were measured at three distinct intervals to track both immediate and sustained effects: at baseline, immediately following the completion of the intervention, and at a 3 month post-intervention follow-up. By utilizing this longitudinal assessment schedule, the study aimed to determine if the cognitive gains observed in the acute phase of recovery would translate into long-term functional stability for patients living in the community.

Evaluating Cognitive and Quality of Life Metrics

To quantify the impact of the Optimizing Participation after Stroke through Strategy training program, the researchers utilized a comprehensive battery of neuropsychological instruments focused on executive function and processing speed. Primary cognitive outcomes included the Trail Making Test Part A (TMT-A), which measures visual scanning and motor speed, and the Trail Making Test Part B (TMT-B), which assesses more complex mental flexibility and task switching. The authors also calculated the difference between Trail Making Test Part B and Part A (TMT B-A) to isolate the executive component of the task by controlling for baseline motor speed. Further executive assessments included the Stroop Color-Naming Test (SCN) and the Stroop Color-Word Interference Test (SCW), the latter of which requires patients to inhibit a dominant response to name the ink color of a conflicting word. To specifically measure the degree of cognitive interference, the researchers calculated the Stroop ratio score (SCW/SCN), providing a standardized metric of inhibitory control. Beyond cognitive performance, the study evaluated health-related quality of life (HRQoL) using the EQ-5D-3L instrument to determine how cognitive gains might translate to patient well-being. These metrics included time trade-off (TTO) values, a measure of health state utility where patients indicate how many years of life they would be willing to trade in a less-than-perfect health state for a shorter duration in perfect health. Additionally, the researchers collected visual analog scale (VAS) values from the EQ-5D-3L, allowing participants to provide a subjective rating of their overall health status on a scale from 0 to 100. To ensure the integrity of the findings across the 195 participants, the authors employed a modified intention-to-treat analysis conducted using non-parametric statistics, an approach that accounts for all randomized participants while accommodating data that may not follow a normal distribution.

Transient Gains in Executive Function

The primary analysis of the Optimizing Participation after Stroke through Strategy training (OPASS) program revealed that the intervention led to greater improvements in Trail Making Test Part B (TMT-B) scores immediately post-intervention compared to the control group (r = 0.19; P = 0.007). This finding suggests that the participation-focused strategy training may produce immediate benefits in executive function, which encompasses the mental skills required for managing time, maintaining attention, and switching focus between tasks, among stroke survivors with cognitive impairments. However, these cognitive gains appeared to be short-lived. The researchers observed that the improvement in TMT-B performance did not persist at the three-month follow-up assessment (r = 0.09; P = 0.231), indicating that the initial boost in mental flexibility and task switching was not maintained once the active intervention phase concluded. Beyond the immediate gains in TMT-B, the study found that no significant between-group differences were present for other cognitive or health-related quality of life outcomes. Specifically, the OPASS group did not show superior performance over the dose-matched control group in measures such as the Stroop Color-Word Interference Test or the EQ-5D-3L time trade-off and visual analog scale values at any time point. While the data indicate that the OPASS program may provide a temporary enhancement of executive function in this clinical population, the lack of long-term retention and the absence of broader impact on quality of life metrics suggest that the current protocol may require refinement. The authors conclude that further trials are warranted to evaluate participation-focused strategy training and to determine how to extend the durability of these cognitive benefits for community-dwelling stroke survivors.

Correlation Between Processing Speed and Quality of Life

Post-stroke cognitive impairment remains a prevalent and disabling condition for survivors, yet clinical evidence supporting the benefits of participation-focused strategy training for improving cognitive function and health-related quality of life (HRQoL) is currently limited. To address this gap, the researchers examined associations between cognitive performance and HRQoL outcomes over time to determine how objective mental processing relates to a patient's perceived health utility. These longitudinal assessments are critical for clinicians to understand whether improvements in specific cognitive domains translate into meaningful changes in how patients value their daily health status. At the three-month follow-up, the study identified significant links between processing speed and subjective well-being. The Trail Making Test Part A (TMT-A), which measures visual scanning and motor speed, was moderately associated with time trade-off (TTO) values (rho = -0.45; P < 0.001). The time trade-off is a metric where patients indicate how many years of life they would be willing to sacrifice to live in full health rather than their current state. Additionally, the TMT-A showed a weak association with the visual analog scale (VAS) (rho = -0.21; P = 0.003), a tool where patients provide a global rating of their health on a scale from 0 to 100. These findings suggest that while executive function gains may be transient, a survivor's underlying processing speed remains a relevant indicator of their perceived quality of life during the recovery period.

References

1. Zhao Q, Wang X, Wang T, et al. Cognitive rehabilitation interventions after stroke: protocol for a systematic review and meta-analysis of randomized controlled trials.. Systematic reviews. 2021. doi:10.1186/s13643-021-01607-7

2. Niu H, Li W, Du L, et al. Comparative efficacy of non-pharmacological interventions for post-stroke cognitive impairment: a systematic review and network meta-analysis of randomized controlled trials.. Frontiers in neurology. 2026. doi:10.3389/fneur.2026.1644663

3. Alashram AR, Annino G, Padua E. Rehabilitation interventions for cognitive deficits in stroke survivors: A systematic review of randomized controlled trials.. Applied neuropsychology. Adult. 2025. doi:10.1080/23279095.2022.2130319

4. O'Donoghue M, Leahy S, Boland P, Galvin R, McManus J, Hayes S. Rehabilitation of Cognitive Deficits Poststroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Stroke. 2022. doi:10.1161/STROKEAHA.121.034218